Followers | 863 |
Posts | 35386 |
Boards Moderated | 20 |
Alias Born | 03/22/2016 |

Saturday, February 15, 2025 5:24:26 AM
Recent GLYC News
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/28/2025 10:05:14 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/27/2025 11:01:22 AM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/25/2025 10:00:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2025 10:00:09 PM
- Form S-4 - Registration of securities, business combinations • Edgar (US Regulatory) • 02/18/2025 10:13:52 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/14/2025 11:38:34 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/14/2025 09:35:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2025 09:35:12 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/13/2025 09:30:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2025 10:00:19 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/13/2025 02:00:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 02:00:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2024 09:30:19 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/27/2024 07:22:44 PM
- Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 • PR Newswire (US) • 11/12/2024 01:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/07/2024 09:47:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:42:19 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/06/2024 10:41:38 PM
- GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting • Business Wire • 11/06/2024 12:00:00 PM
- Form SC 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 11/04/2024 09:26:15 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/04/2024 07:01:21 PM
- Biotech Up Over +100% Premarket Following Merger And Funding Announcement • AllPennyStocks.com • 10/29/2024 02:00:00 PM
- Shares of Biotech Company Up Over 100% Premarket Following Merger & Funding Announcement • AllPennyStocks.com • 10/29/2024 02:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/29/2024 12:09:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 12:09:13 PM
LaFleur Minerals Provides Update on Beacon Mill Restart, Results of Annual General and Special Meeting, and Swanson Gold Deposit Exploration and Drilling Updates • LFLRF • Mar 21, 2025 9:40 AM
Basanite Industries, Inc. Appoints Michael D. Nelson as Chief Executive Officer • BASA • Mar 21, 2025 9:01 AM
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation • FITY • Mar 20, 2025 9:00 AM
VAYK Forms Partnership with Airbnb Investing Group to Offer Service Solution • VAYK • Mar 20, 2025 9:00 AM
4Cable TV International, Inc. (CATV) Facilitates Acquisition of Genetic Networks LLC by Fifty 1 Labs, Inc. (FITY), Announces Dividend for CATV Shareholders, and Sets Stage for Transformative Reverse Merger • CATV • Mar 20, 2025 8:30 AM
NUBURU Announces Elimination of 100% of its Long-Term Indebtedness and $5.15 Million Strategic Investment in Supply@ME Capital • BURU • Mar 19, 2025 8:53 AM